Authored: 11/11/2025


Nevolat (liraglutide) is a prescription-only GLP-1 weight loss injection. It contains the same active ingredient as Saxenda and helps regulate appetite and blood sugar levels. Used alongside a balanced diet and increased physical activity, Nevolat can help you lose weight.
Overview
You can buy liraglutide online as Nevolat or Saxenda from our UK-registered online pharmacy if prescribed.
This once daily injection helps people lose weight by reducing hunger and helping to control portion sizes.
Nevolat is available to order after completing a short assessment. If you're eligible for a prescription, our clinical team will process your treatment.
Nevolat is the generic version of Saxenda, this means they both contain the same active ingredient, liraglutide. Sometimes referred to as generic liraglutide.
This prescription-only medicine supports obesity management alongside a healthy diet and regular exercise.
Nevolat is part of the glucagon like peptide-1 (GLP-1) receptor agonist family. It works by mimicking a natural hormone that regulates appetite.
Nevolat comes as a pre-filled injectable pen used once-daily under the skin of the abdomen, thigh, or upper arm.
You may be prescribed Nevolat if you:
Liraglutide is not suitable for:
As part of the review process our clinical team consider possible interactions with other medication.
Liraglutide is a GLP-1 receptor agonist. It works by mimicking a natural hormone, glucagon like peptide-1.
After eating, GLP-1 is released by your body. This sends a signal to the brain to signify satiety. In other words, the feeling of being full.
These receptors control feelings of hunger and how long the emptying of your stomach takes. Overall, this helps you feel fuller for longer - reducing snacking.
It works by helping:
For more information, see the Patient Information Leaflet (PIL).
Clinical trials show that patients using liraglutide over 12 months lost between 5-10% of their body weight.
If you lose less than 5% of your starting weight after 12 weeks on the full dose, your clinician may review your treatment.
Nevolat supports obesity management by reducing food noise and craving control. This may reduce the risk of other weight related problems.
| Pack Size | Price | Approx. Duration for New Starters (with titration) | Approx. Duration at Maintenance (3 mg/day) |
|---|---|---|---|
| 1 pen | £69 | 17 days (~2.5 weeks) | ~6 days |
| 2 pens | £135 | 25.5 days (~3.6 weeks) | ~12 days |
| 3 pens | £200 | 31.5 days (~4.5 weeks) | ~18 days |
| 4 pens | £265 | 37.5 days (~5.3 weeks) | ~24 days |
| 5 pens | £325 | 43.5 days (~6.2 weeks) | ~30 days |
Nevolat titration - Doses increases gradually to help your body adjust and reduce side effects.
Starting at 0.6mg, then increasing weekly until you reach your maintenance dose. When moving to the next dose, simply adjust the pen to required dose.
Inject once each day, ideally at the same time, as directed by your clinician.
Daily Dose
It varies depending on which dose you are on. Your clinician will confirm when to move to the next dose and monitor your progress.
0.6mg daily dose - 30 days per pen
1.2mg daily dose - 15 days per pen
1.8mg daily dose - 10 days per pen
2.4mg daily dose - 7.5 days per pen
3.0mg daily dose - 6 days per pen
The duration changes per person depending on their own weight loss journey. Normally after implementing healthy habits and achieving a healthy weight patients may look at coming off the medication.
Nevolat is safe to take long-term with medical supervision.
Patients experiencing side effects may decide to stop or change their weight loss medication.
Nevolat comes as a pre-filled injection pen that can be adjusted to deliver a precise dose.
Keep unused pens refrigerated at a temperature between 2°C and 8°C. Ensure your medication is away from the freezer compartment.
Once opened and in use, Nevolat pens can be kept at room temperature (below 30°C) for up to 30 days. After this time any remaining medicine should be safely discarded - even if some is still left in the pen.
Do not freeze Nevolat pens or expose them to direct heat or sunlight, as this can damage the medicine. When travelling, carry your pens in an insulated pouch or cool bag to keep them at a safe temperature.
Like all medicines, Nevolat may cause side effects. Most side effects are mild and ease as the dose gradually increases.
Common side effects include:
Serious but rare side effects include:
Always read the Patient Information Leaflet (PIL) before taking any medication.
Seek medical help if you have severe stomach pain, yellowing of the skin, or difficulty swallowing.
Always report any side effects that are not on this list to your prescribing doctor and MHRA Yellow Card.
If Nevolat (or Saxenda) aren't suitable, other GLP-1 treatments may be more suitable, such as:
Other options include Orlistat (Xenical), an oral capsule that reduces fat absorption during digestion.
All of our medication and condition content is written by UK qualified pharmacists and doctors.
Authored: 11/11/2025

Reviewed: 11/11/2025

FAQ
Doctors prescribe liraglutide to treat both conditions. At higher doses, it helps adults manage obesity. At lower doses, under the brand name Victoza, it treats type 2 diabetes.
Yes. Saxenda and Nevolat contain the same active ingredient, liraglutide. Both weight loss injection pens work in the same way to reduce appetite and support weight loss.
Nevolat contains liraglutide, while Mounjaro contains tirzepatide.
Both are injectable treatments that help regulate appetite, but they act on different hormone pathways.
Mounjaro is a dual receptor agonist, targeting two receptors (GLP-1 and GIP), whereas Nevolat targets one (GLP-1). Your clinician will advise which is best suited to you.
Neither medicine is universally better. Both are prescription-only treatments. Licenced to support weight loss and obesity management.
Nevolat contains liraglutide, while Mounjaro contains tirzepatide. They work in similar ways but act on slightly different hormone pathways.
Clinical studies have shown Mounjaro to produce greater average weight loss. Whereas Nevolat has a longer track record of use and established safety data.
The right option depends on individual health requirments, and how your body responds to treatment. Your clinician will consider your medical history, other medicines before recommending the most suitable choice.
Take Nevolat injection once daily, ideally at the same time each day, by subcutaneous injection.
Use the pre-filled pen to deliver the dose by injecting under the skin of your abdomen, thigh, or upper arm. Rotate the injection site each day to protect the skin.
If you miss a dose. Take it as soon as possible with in the first 12-hour window. If more than 12 hours have passed, skip the missed dose and take your next at the usual time.
Do not take an additional dose to compensate for a missed injection.
Stopping treatment may result in weight regain. Always discuss any decision to stop with your clinician.
Most patients notice a reduced appetite within a few days of starting treatment. Weight loss usually becomes noticeable after three to six months.
If your weight loss has slowed, your clinician may check your dose and activity levels. They may also refer you to one of our dietitians for further support.
For best results it’s important to reach the full maintenance dose and maintain a balanced diet to achieve the best results.
Light to moderate alcohol intake is usually acceptable, but alcohol can worsen nausea or affect blood-sugar control.
When prescribed by a qualified clinician, Nevolat is a safe and effective treatment for obesity management.
Liraglutide has been widely studied and used under medical supervision.
Like any prescription treatment, it may not suit everyone. Your clinician will review before prescribing to ensure it is safe for you.
These are usually mild and improve over time.
Consume smaller, lighter meals, limit high-fat foods, and stay well hydrated.
Rare but serious Nevolat side effects can include:
Seek medical advice immediately if you develop
The risk increases only when used with other glucose-lowering medicines.
This treatment is not suitable for everyone. It should be avoided by people who:
Always tell your doctor about any health problems or medicines you take before starting treatment.
Do not use if pregnant or breastfeeding.
If you are planning to pregnancy, consult your doctor for medical advice. They may recommend stopping your treatment and exploring other options.
Keep unused pens in a refrigerator. Once opened you can keep the pens at room temperature, below 30 °C, for up to 30 days.
Yes. Keep them away from direct heat and freezing temperatures. If possible, carry your pens in an insulated container with ice gel packs.
Once removed from the cold chain, a pen remains stable for up to 30 days when stored at room temperature (below 30°C).
Do not use this medicine if the solution is not clear and colourless or almost colourless.
Yes, if you meet the eligibility criteria for a prescription.
As a prescription-only medication, a clinician must first review and confirm that it is suitable for you.
If prescribed, a GPhC-registered pharmacist will prepare your treatment. Your order is then carefully packaged and dispatched.
Yes, but only if you meet strict criteria.
The NHS Tier 3 weight management services may prescribe them after a GP referral.
To qualify, patients must have a BMI of 40 or higher. They must also have at least four of the following five weight-related health conditions:
Yes. Liraglutide is a prescription-only medicine. A qualified clinician can prescribe Saxenda or Nevolat weight loss injections after an online or in-person medical assessment.
Compare
| Saxenda | Xenical | Orlistat | Mysimba | |
| Ingredient | Liraglutide | Orlistat 120mg | Orlistat 120mg | Naltrexone/Bupropion |
| Mechanism | Regulates appetite | Reduces fat absorption | Reduces fat absorption | Regulates appetite |
| Dose | Injected once daily | One three times daily with meals | One three times daily with meals | Gradually increased to 4 tablets daily |
Reviews